
Purna Pharma Private Limited
Manufactures and sells pharmaceutical and chemical products for medicinal purposes.
Manufactures and sells pharmaceutical and chemical products for medicinal purposes.
Howrah, West Bengal, India
+91-XXXXXXXXXX
U74900WB2015PTC206920
206920
Private Limited Indian Non-Government Company
30 Jun 2015
29 Sep 2017
31 Mar 2017
Unlisted
Roc Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandeep Kumar ![]() | Director | 27-Jan-2017 | Current |
Aarti Sharma ![]() | Director | 27-Jan-2017 | Current |
Purna Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.13% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.39%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2017, Purna Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Purna Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Purna Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purna Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Purna Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records.
Purna Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Kolkata.
Sandeep Kumar was appointed as a Director was appointed as a Director on 27 Jan 2017 & has been associated with this company since 8 years 3 months .
Aarti Sharma was appointed as a Director was appointed as a Director on 27 Jan 2017 & has been associated with this company since 8 years 3 months .
Purna Pharma Private Limited was registered on 30 Jun 2015 with Roc Kolkata & aged 9 years 10 months as per MCA records.
Purna Pharma Private Limited was incorporated on 30 Jun 2015.
The authorized share capital of Purna Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Purna Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Purna Pharma Private Limited is 24/25 Dobson Road, Ground Floor, Howrah, West Bengal, India, 711101.
The corporate identification number (CIN) of Purna Pharma Private Limited is U74900WB2015PTC206920 and the company number is 206920 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2017 indicates that The net worth of Purna Pharma Private Limited has experienced an downturn of -10.39%.
The most recent Balance Sheet for Purna Pharma Private Limited was filed with the ROC on 31 Mar 2017.
Search company & director profiles for free and gain access to critical business data.
AB
NB